Acute Kidney Injury in Liver Disease: Role of Biomarkers

Advances in Chronic Kidney Disease

Volumn 22, Issue 5, 2015, Pages 368-375

  Belcher, Justin M ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Acute kidney injury; Biomarkers; Cirrhosis; Differential diagnosis; Prognosis

Indexed keywords

BIOLOGICAL MARKER; CREATININE; GLUTATHIONE TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE P1; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TOLL LIKE RECEPTOR 4; MEMBRANE PROTEIN;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; GLOMERULUS FILTRATION RATE; HEPATORENAL SYNDROME; HUMAN; INTERMETHOD COMPARISON; LIVER DISEASE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; REVIEW; SODIUM EXCRETION; ACUTE KIDNEY INJURY; ALBUMINURIA; BLOOD; COMPLICATION; DISEASE COURSE; FEMALE; LIVER CIRRHOSIS; MALE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; SURVIVAL RATE;

ACUTE KIDNEY INJURY; ALBUMINURIA; BIOMARKERS; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LIVER CIRRHOSIS; MALE; MEMBRANE GLYCOPROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEINURIA; SURVIVAL RATE;

EID: 84951970981     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2015.06.009     Document Type: Review

References (43)

1. Garcia-Tsao G., Parikh C.R., Viola A. Acute kidney injury in cirrhosis. Hepatology 2008, 48(6):2064-2077.
2. Du Cheyron D., Bouchet B., Parienti J.J., Ramakers M., Carbonneau P. The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med 2005, 31(12):1693-1699.
3. Fang J.T., Tsai M.H., Tian Y.C., et al. Outcome predictors and new score of critically ill cirrhotic patients with acute renal failure. Nephrol Dial Transplant 2008, 23(6):1961-1969.
4. Cholongitas E., Senzolo M., Patch D., Shaw S., O'Beirne J., Burroughs A.K. Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality. Eur J Gastroenterol Hepatol 2009, 21(7):744-750.
5. Hsu C.Y., McCulloch C.E., Fan D., Ordonez J.D., Chertow G.M., Go A.S. Community-based incidence of acute renal failure. Kidney Int 2007, 72(2):208-212.
6. Martin-Llahi M., Guevara M., Torre A., et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 2010, 140(2):488-496.
7. Hampel H., Bynum G.D., Zamora E., El-Serag H.B. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol 2001, 96(7):2206-2210.
8. Peron J.M., Bureau C., Gonzalez L., et al. Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study. Am J Gastroenterol 2005, 100(12):2702-2707.
9. Terra C., Guevara M., Torre A., et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 2005, 129(6):1944-1953.
10. Du Cheyron D., Bouchet B., Parienti J.J., Ramakers M., Charbonneau P. The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med 2005, 31(12):1693-1699.
11. Wu C.C., Yeung L.K., Tsai W.S., et al. Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis. Clin Nephrol 2006, 65(1):28-33.
12. Moreau R., Durand F., Poynard T., et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 2002, 122(4):923-930.
13. Schrier R.W. Fluid administration in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 2010, 5(4):733-739.
14. Dobre M., Demirjian S., Sehgal A.R., Navaneethan S.D. Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis. Int Urol Nephrol 2011, 43(1):175-184.
15. Nadim M.K., Genyk Y.S., Tokin C., et al. Impact of etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome. Liver Transpl 2012, 18(5):539-548.
16. Magri P., Auletta M., Andreucci M., et al. Sodium retention in preascitic stage of cirrhosis. Semin Nephrol 2001, 21(3):317-322.
17. Diamond J.R., Yoburn D.C. Nonoligouric acute renal failure associated with a low fractional excretion of sodium. Ann Intern Med 1982, 96(5):597-600.
18. Salerno F., Gerbes A., Gines P., et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007, 56(9):1310-1318.
19. Abuelo J.G. Normotensive ischemic acute renal failure. N Engl J Med 2007, 357(8):797-805.
20. Verna E.C., Brown R.S., Farrand E., et al. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci 2012, 57(9):2362-2370.
21. Kidney Disease Improving Global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2012, 2(Suppl 1):1-138.
22. Angeli P., Ginés P., Wong F., et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Ascites Club. J Hepatol 2015, 62(4):968-974.
23. Belcher J.M., Edelstein C.L., Parikh C.R. Clinical applications of biomarkers for acute kidney injury. Am J Kidney Dis 2011, 57(6):930-940.
24. Krawczeski C.D., Goldstein S.L., Woo J., et al. Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol 2011, 58(22):2301-2309.
25. Parikh C.R., Coca S.G., Thiessen-Philbrook H., et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 2011, 22(9):1748-1757.
26. Nisula S., Yang R., Poukkanen M., et al. Predictive value of urine interleukin-18 in the evaluation and outcome of acute kidney injury in critically ill adult patients. Br J Anaesth 2015, 114(3):460-468.
27. Tasanarong A., Hutayanon P., Piyayotai D. Urinary neutrophil gelatinase-associated lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures. BMC Nephrol 2013, 5(14):270.
28. Hall I.E., Yarlagadda S.G., Coca S.G., et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol 2010, 21(1):189-197.
29. Hall I.E., Coca S.G., Perazella M.A., et al. Risk of poor outcomes with novel and traditional biomarkers at clinical diagnosis. Clin J Am Soc Nephrol 2011, 6(12):2740-2749.
30. th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care 2012, 16(1):R23.
31. Fagundes C., Pépin M.N., Guevara M., et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J Hepatol 2012, 57(2):267-273.
32. Qasem A.A., Farag S.E., Hamed E., et al. Urinary biomarkers of acute kidney injury in patients with cirrhosis. ISRN Nephrol 2014, 376795.
33. Shah N., Mohamed F.E., Jover-Cobos M., et al. Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis. Liver Int 2013, 33(3):398-409.
34. Belcher J.M., Sanyal A.J., Peixoto A.J., et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology 2014, 60(2):622-632.
35. Barreto R., Elia C., Solà E., et al. Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcomes and death in patients with cirrhosis and bacterial infections. J Hepatol 2014, 61(1):35-42.
36. Mårtensson J., Xu S., Bell M., Martling C.R., Venge P. Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils. Clin Chim Acta 2012, 413(19-20):1661-1667.
37. Gungor G., Ataseven H., Demir A., et al. Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study. Liver Int 2014, 34(1):49-57.
38. Tsai M.H., Chen Y.C., Yang C.W., et al. Acute renal failure in cirrhotic patients with severe sepsis: Values or urinary interleukin-18. J Gastroenterol Hepatol 2013, 28(1):135-141.
39. Slack A.J., McPhail M.J., Ostermann M., et al. Predicting the development of acute kidney injury in liver cirrhosis-an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers. Aliment Pharmacol Ther 2013, 37(10):989-997.
40. Belcher J.M., Garcia-Tsao G., Sanyal A.J., et al. Urinary biomarkers and progression of AKI in patients with cirrhosis. Clin J Am Soc Nephrol 2014, 9(11):1857-1867.
41. Mandal A.K., Lansing M., Fahmy A. Acute tubular necrosis in hepatorenal syndrome: an electron microscopy study. Am J Kidney Dis 1982, 2(3):363-374.
42. Kanel G.C., Peter R.L. Glomerular tubular reflex. A morphologic renal lesion associated with the hepatorenal syndrome. Hepatology 1984, 4(2):242-246.
43. Endre Z.H., Kellum J.A., Di Somma S., et al. Differential diagnosis of AKI in clinical practice by functional and damage biomarkers: work-group statements from the Tenth Annual Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 2013, 182:30-44.